Salmon Oil EPA
Supplies Omega 3 Fatty Acids
| $7.99 | 100 Count Bottle VP2039R | Retails for $9.90 | |
| $79.99 | 12 Bottles 100 Count Each | Retail Value $118.80 | |
| $19.99 | 250 Count Bottle VP2039U | Retails for $23.90 | |
|
Display An Attractive 12 Bottle Case On Your Counter for Patient/Client Convenience. Additional Wholesale Discounts Available |
|||
Salmon Oil is regarded as one of the best known sources of natural EPA.
As a convenient method of adding Salmon Oil to your dietary intake, this capsule supplies superior quality EPA extracted from fresh cold water Salmon, naturally rich in Omega-3 Fatty Acids!
No caffeine, corn, gluten, milk or egg derivatives, salt, sodium, soy, starch, wheat or yeast; No artificial colorings, flavorings or preservatives.
Find Salmon Oil Supplements at a Featured Merchant (below)
Omega-3 oils which are rich in EPA & DHA have been found to keep blood free flowing, vessels flexible and help protect people from heart attacks.
Omega-3 supplements which are high in EPA and DHA also can help people with depression, PMS, arthritis and other inflammations, such as migraines. They’re also important during pregnancy, nursing and infancy when a baby’s eyes, nerves and brain are developing.
Reduce Hostility With Fish Oil Intake
Fish Oil “Omega 3 Fatty Acid” (DHA) Reduces the Tendency for Hostility in Young Adults
A cross-sectional observational study analyzed 3,581 urban black and white young adults between the ages 18 and 30 for hostility levels based upon their dietary fatty acid intakes. Data obtained from hostility measurements in 1990-1991 and dietary assessments in 1992-1993 were used in this study. Analysis of this data after adjustment for multiple variables revealed a significant inverse association between fatty fish intake and hostility. No association was observed between total omega-6 fatty acid intake ratios and hostility. The researchers concluded that regular consumption of fish rich in omega-3 fatty acids, (particularly DHA) is associated with reduced odds for hostility. Fish oil “Omega 3 Fatty Acid” intake affect mood, especially when you consider a high percentage of the fat in the brain is DHA.
E.J. Clin. Nutr. 2004; 50:24-31.
Potential Role of Fish-Based Omega-3 Fatty Acids In Managing and Helping Prevent Asthma
In an ongoing effort to determine the anti-inflammatory value of diets rich in some types of fish, scientists studying asthma and allergic reactions have found that a molecule produced by the body from Omega-3 fatty acids in Salmon, Mackerel and Anchovies helps resolve and prevent respiratory distress in laboratory mice.
The research, supported by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, was led by a research team at Brigham and Women's Hospital and Harvard Medical School.
Resolvin E1 (RvE1) is a metabolic by-product of a specific Omega-3 fatty acid naturally present in cold-water fish (including salmon, mackerel and anchovies). It is produced by the body in response to the onset of inflammation. This study identified RvE1 as having a key role in both dampening the development of airway inflammation and promoting its resolution, by helping dampen innate immune signals that trigger inflammation.
Other studies have indicated that increased levels of Omega-3 fatty acids are associated with lower asthma prevalence in people, but the mechanisms to support that observation are not yet fully understood. The new study provides scientists an opportunity to focus on the role of a diet rich in Omega-3 fatty acids from cold water fish as a valuable therapeutic agent for helping thwart asthma.
New Study Confirms Supplement Use Improves Health and Reduces Health Care Costs
A recent study conducted by The Lewin Group confirms that taking certain dietary supplements can help seniors live longer and lead more productive independent lives while reducing health care costs by billions of dollars.
Here are some key findings of the study, which was commissioned by the Dietary Supplement Education Alliance (DSEA):
- The supplements studied – Omega-3 Fatty Acids (fish oil capsules) and Lutein (with zeaxanthin) – have reported savings of $3.1 billion and $2.5 billion respectively over five years, resulting from reduced doctors' visits, hospitalizations, and avoided transitions to dependency.
- Omega-3 Fatty Acids and Lutein (with zeaxanthin) are natural nutritional supplements allowing seniors to help avoid common conditions such as coronary heart disease (CHD) and age- related macular degeneration (AMD).
- Daily intake of at least 1,800 milligrams of Omega-3 by Americans over the age of 65 can reduce the occurrence of CHD, resulting in a potential five-year (2006-2010) savings of $3.1 billion in health care expenditures and an estimated 384,303 fewer hospitalizations.
- Daily intake of 6-10 milligrams (or more) of Lutein (with zeaxanthin) by seniors can reduce the relative risk of AMD, resulting in an estimated five-year (2006- 2010) net savings of $2.5 billion from the avoided transition of approximately 98,219 individuals to dependency either in the community or a nursing facility.
New Study Strongly Recommends Omega-3 Fish Oils In The Fight Against Cancer ...
The key Omege-3 Fatty Acid Docosahexanoic acid (DHA), naturally present in fish oils, has been shown to reduce the size of tumors and also enhance the positive effects of the chemotherapy drug cisplatin, while limiting its harmful side effects.
The controlled laboratory experiments provide additional support for the wealth of health benefits often ascribed to Omega-3 Acids from Salmon and cold water fish oils.
Researchers from Mansoura University, Egypt, who studied DHA's effects on solid tumors growing in laboratory mice, as well as investigating how the specific Omega-3 fatty acid DHA interacts with cisplatin, a chemotherapy drug that is known to cause kidney damage. The lead researcher explained DHA elicited prominent chemo-preventive effects on its own, and appreciably augmented those of cisplatin as well. This important new study is the first to reveal that DHA can obliterate lethal cisplatin-induced nephrotoxicity and renal tissue injury.
DHA is an Omega-3 fatty acid that is commonly found in cold-water fish oil, as well as some vegetable oils. It is a major component of brain gray matter and of the retina in most mammalian species and is considered essential for normal neurological and cellular developments.
According to the study's authors, DHA has been tentatively linked with protection against cardiovascular, neurological and neoplastic diseases, however, there 's limited research information regarding its interactions with existing chemotherapy drugs.
The researchers discovered that, at the molecular level, DHA acts by reducing leukocytosis (white blood cell accumulation), systemic inflammation, and oxidative stress all processes that have been linked with tumor growth.
The researchers strongly recommend greater deployment of Omega-3 in the fight against cancer. They explain "Our results suggest a new, fruitful drug regimen in the management of solid tumors based on combining cisplatin, and possibly other chemotherapeutics with DHA".
Journal reference: M E Elmesery, M M Algayyar, H A Salem, M M Darweish and A M El-Mowafy. "Chemopreventive and renal protective effects for docosahexaenoic acid (DHA): implications of CRP and lipid peroxides."
Omega-3 Fatty Acids EPA & DHA Linked To Lower Incidence of Obesity
Increased Blood Levels of The Omega-3 Fatty Acids EPA and DHA are Linked to Lower Incidence of Obesity, Suggesting a Role For Fish Oils in Weight Management.
New findings reported in the British Journal of Nutrition indicate that overweight and obese people have blood levels of Omega-3 fatty acids typically lower than people with a healthy weight.
This study suggests that Omega-3 from fish oils may play an important role in weight status and abdominal adiposity, noted the researchers from the University of Newcastle of the Nutrition Society of Australia.
Previous studies have reported Omega-3 in protective benefits against obesity, and the new study adds to this growing body of evidence. A considerable number of studies already support the benefits of the Omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) for cardiovascular health, and cognitive health. Other areas of potential for the fatty acids include mood and behaviour, eye health, cancer risk reduction, and improved infant development.
The researchers recruited 124 people of varying weights: 21 were classified as having a healthy weight, according to their body mass index (BMI); 40 were classed as overweight; and 63 were obese. The researchers note that people who consumed Omega-3 supplements were excluded from their study.
Blood samples were taken after the subjects fasted for at least ten hours. The researchers recorded an inverse relationship between total omega-3 blood levels, as well as blood levels of DHA and EPA, with BMI, the subject's waist size, and their hip circumference.
The obese people had omega-3 levels of 4.53 per cent, compared to 5.25 per cent in their healthy-weight peers. When the researchers classed the people according to their Omega-3 levels, and not by their weight, they again observed that increased omega-3 levels were associated with a healthier BMI, a smaller waist, and a lower hip size. "Other studies, along with our observations, suggest that Omega-3 supplementation may play an important role in preventing weight gain and improving weight loss when Omega-3 fatty acids are supplemented with a structured weight-loss program," wrote the researchers.
